Lipid Complications after Hematopoietic Stem Cell Transplantation (HSCT) in Pediatric Patients
HSCT (hematopoietic stem cell transplantation) is a widely applied method of treatment of pediatric patients with leukemia and other bone marrow-associated disorders. Metabolic disturbances can appear as procedure side effects. This study aimed to report incidence of lipid and thyroid disorders and...
Main Authors: | Gabriela Bis, Wojciech Szlasa, Katarzyna Sondaj, Iga Zendran, Monika Mielcarek-Siedziuk, Ewa Barg |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/12/9/2500 |
Similar Items
-
Quality of Life and Psychopathology in Adults Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) in Childhood: A Qualitative and Quantitative Analysis
by: Francesco Sinatora, et al.
Published: (2017-08-01) -
Evaluation of Plasma Concentration and Hepatotoxicity of Voriconazole in Pediatric Patients following Hematopoietic Stem Cell Transplantation
by: Hamidreza Taghvaye Masoumi, et al.
Published: (2017-09-01) -
Prevention and management of human cytomegalovirus in pediatric HSCT recipients: A review
by: Lisa Hiskey, et al.
Published: (2022-11-01) -
Oral Cancer in HSCT Pediatric Patients Arising on GVHD: A Comprehensive Review
by: Tiziana Cantile, et al.
Published: (2022-11-01) -
Prognostic factors and predictive scores for 6-months mortality of hematopoietic stem cell transplantation recipients admitted to the pediatric intensive care unit
by: Sarah Schober, et al.
Published: (2023-09-01)